Clinical Trials · NCT06515418
Efficacy and Safety of Oral Azelaprag Plus Once Weekly Tirzepatide Compared with Tirzepatide Alone in Participants with Obesity Aged 55 Years and Over
- Phase
- Phase 2
- Recruitment status
- Terminated
- Sponsor
- BioAge Labs, Inc.
- Enrollment
- 204
- Start date
- Jun 2024
- Locations
- 14 sites, United States
- Primary endpoint
- Mean Percent Change in Body Weight (Azelaprag Once per Day)